Live from the NIH registry
Studies recruiting near Buffalo right now
Top 25 of 517 recruiting studies, sorted by proximity — each links to its official registry page
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Roswell Park Cancer Institute — Buffalo, New York (1.8 mi)
· Sponsor: SWOG Cancer Research Network
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma
Phase 2
Interventional 81 participants sought
Roswell Park Cancer Institute — Buffalo, New York (1.8 mi)
· Sponsor: National Cancer Institute (NCI)
Inhaled Isopropyl Alcohol for Treatment of Nausea
Vomiting, Nausea
Phase 2, Phase 3
Interventional 84 participants sought
Oishei Children's Hospital — Buffalo, New York (1.8 mi)
· Sponsor: State University of New York at Buffalo
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Roswell Park Cancer Institute — Buffalo, New York (1.8 mi)
· Sponsor: National Cancer Institute (NCI)
Generating Novel Translational and Therapeutic Strategies Based on a Multicenter, Pediatric and AYA Evolutionary Tumor Board (pedsETB)
Pediatric Cancer
N/A
Observational 35 participants sought
Roswell Park Comprehensive Cancer Center — Buffalo, New York (1.8 mi)
· Sponsor: H. Lee Moffitt Cancer Center and Research Institute
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Lymphoma, Large B-Cell, Diffuse
Phase 2
Interventional 594 participants sought
Erie County Medical Center ( Site 0175) — Buffalo, New York (1.8 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University Telemedicine — Buffalo, New York (1.8 mi)
· Sponsor: Sameek Roychowdhury
ELEVATE High-Risk PCI Pivotal Study
High-Risk Percutaneous Coronary Intervention (High-risk PCI)
N/A
Interventional 290 participants sought
Buffalo General Medical Center — Buffalo, New York (1.8 mi)
· Sponsor: Magenta Medical Ltd.
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Solid Tumor, Non-Small-Cell Lung Cancer
Phase 1
Interventional 364 participants sought
Roswell Cancer Institute — Buffalo, New York (1.8 mi)
· Sponsor: Astellas Pharma Inc
The GORE VBX FORWARD Clinical Study: A Comparison of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis to Bare Metal Stenting for Patients With Complex Iliac Occlusive Disease
Aortoiliac Occlusive Disease, Peripheral Arterial Disease
N/A
Interventional 244 participants sought
Trinity Medical Center — Buffalo, New York (1.8 mi)
· Sponsor: W.L.Gore & Associates
A Study of JNJ-86974680 in Participants With Advanced Non-small Cell Lung Cancer
Carcinoma, Non-small-Cell Lung
Phase 1
Interventional 126 participants sought
Roswell Park Comprehensive Cancer Center — Buffalo, New York (1.8 mi)
· Sponsor: Johnson & Johnson Enterprise Innovation Inc.
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
Leukemia, Leukemia, Myeloid
Phase 1
Interventional 170 participants sought
Roswell Park Cancer Institute — Buffalo, New York (1.8 mi)
· Sponsor: BlossomHill Therapeutics
A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia Gravis
Generalized Myasthenia Gravis
Phase 3
Interventional 180 participants sought
Dent Neurological Institute — Buffalo, New York (1.8 mi)
· Sponsor: Novartis Pharmaceuticals
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Percutaneous Coronary Intervention, Peripheral Endovascular Intervention
Phase 4
Interventional 6,000 participants sought
Sisters of Charity Hospital — Buffalo, New York (1.8 mi)
· Sponsor: Duke University
Photoacoustic Imaging of Foot Wound
Foot Ulcer
N/A
Interventional 25 participants sought
UBMD Vascular Surgery — Buffalo, New York (1.8 mi)
· Sponsor: State University of New York at Buffalo
ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valves
Aortic Valve Insufficiency, Aortic Valve Stenosis
N/A
Interventional 200 participants sought
University of Buffalo — Buffalo, New York (1.8 mi)
· Sponsor: Edwards Lifesciences
A Study of ASP3082 in Adults With Advanced Solid Tumors
Solid Tumor
Phase 1
Interventional 681 participants sought
Roswell Park Cancer Institute — Buffalo, New York (1.8 mi)
· Sponsor: Astellas Pharma Inc
MMA Embolization for Refractory Chronic Migraine
Migraine Disorders
N/A
Interventional 70 participants sought
University of Buffalo Medical Center — Buffalo, New York (1.8 mi)
· Sponsor: Cerenovus, Part of DePuy Synthes Products, Inc.
Evaluation of Flow Diverter Technology Device for Intracranial Aneurysm (SHIELD)
Aneurysm
N/A
Interventional 10 participants sought
Jacobs Institute — Buffalo, New York (1.8 mi)
· Sponsor: Jacobs institute
Balance4Mobility: Effects of Walkasins Use in Individuals With Peripheral Neuropathy and Balance Problems
Peripheral Neuropathies, Peripheral Neuropathy Due to Chemotherapy
N/A
Interventional 200 participants sought
Dent Neurologic Institute — Amherst, New York (5.8 mi)
· Sponsor: RxFunction Inc.
Robotic Minimally Invasive Inguinal Hernia Repair Post-Market Clinical Study With the DEXTER Robotic System
Inguinal Hernia Repair
N/A
Observational 140 participants sought
Northtowns Ambulatory Surgical Center (NASC) — Buffalo, New York (1.8 mi)
· Sponsor: Distalmotion SA
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
Large B-cell Lymphoma, Lymphoma, B-Cell
Phase 3
Interventional 400 participants sought
Roswell Park Comprehensive Cancer Center — Buffalo, New York (1.8 mi)
· Sponsor: Lyell Immunopharma, Inc.
Improving Safety and Quality of Tracheal Intubation Practice in Pediatric ICUs
Failed or Difficult Intubation, Sequela, Intubation; Difficult
N/A
Observational 150,000 participants sought
Oishei Children's Hospital — Buffalo, New York (1.8 mi)
· Sponsor: Children's Hospital of Philadelphia
A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer
Low Grade Serous Ovarian Cancer
Phase 3
Interventional 270 participants sought
Roswell Park Cancer Institute — Buffalo, New York (1.8 mi)
· Sponsor: Verastem, Inc.
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Advanced Solid Tumor, Melanoma
Phase 2
Interventional 740 participants sought
Roswell Park Cancer Institute IDS — Buffalo, New York (1.8 mi)
· Sponsor: Daiichi Sankyo